Advertisement

Topics

OptiNose nets $60.1mm via FOPO

19:41 EDT 8 Jun 2018 | Elsevier Business Intelligence

In its first financing since going public, OptiNose Inc. (focused on the ear, nose and throat and allergy space) netted $60.1...

Original Article: OptiNose nets $60.1mm via FOPO

NEXT ARTICLE

More From BioPortfolio on "OptiNose nets $60.1mm via FOPO"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Allergies
The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...